Podcast: Business Intelligence Tools in Radiology
Paul Chang, MD, explains how radiologists are using data analytics and business intelligence to improve efficiency and demonstrate their value in health care.
You can’t improve what you can’t measure, according to Paul Chang, MD, FSIIM, professor and vice chairman of radiology informatics at the University of Chicago School of Medicine, who is speaking at the SIIM 2012 conference in Orlando this week.
In this first part of a two-part podcast series, Chang details why and how radiologists are leveraging business intelligence tools to improve efficiency and quality. He also explains how radiology must look beyond the department and utilize enterprise-wide image management tools to really demonstrate the field’s value and relevance in health care.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
